Assembly Bill 503 seeks to amend the definition of hemp within Wisconsin's Controlled Substances Act. The bill redefines hemp as the plant Cannabis sativa L. and its derivatives, with a total tetrahydrocannabinol (THC) concentration, including tetrahydrocannabinolic acid, of not more than 0.3 percent on a dry weight basis. It also introduces the term "industrial hemp," which encompasses various uses of the plant, such as for stalk, seeds, and edible products. The bill clarifies that hemp does not include certain products, such as viable cannabis seeds exceeding the THC threshold or hemp-derived cannabinoid products that contain synthesized cannabinoids or quantifiable amounts of THC.

Additionally, the bill includes several amendments to existing statutes to align with the new definition of hemp. Notably, it renumbers and amends section 94.55 (1) to introduce new definitions and clarifies that hemp-derived cannabinoid products do not include FDA-approved prescription drugs. The bill also updates language throughout the statutes to replace references to "delta-9-tetrahydrocannabinol" with "tetrahydrocannabinol" and ensures that hemp is not classified as marijuana under the law. Overall, the bill aims to provide a clearer legal framework for the cultivation and use of hemp in Wisconsin.

Statutes affected:
Bill Text: 94.55(2)(b)2m.b, 94.55, 94.55(2)(b)4s, 94.55(3m)(a)2, 94.67(15c), 94.67, 446.01(2)(a), 446.01, 450.03(1)(k), 450.03, 450.07(1m), 450.07, 961.01(14), 961.01, 961.14(4)(t)3, 961.14, 961.32(2m)(b), 961.32, 961.32(3)(a)2